Here we aimed to gain further insight into the molecular mechanisms of the cancer-related functions of this oncogene. We performed 2D-DIGE proteome analysis of tumor material from patients with NSCLC and of HEK293 cells stably overexpressing plasmid-encoded SEC62, combined with investigation of the Sec62 interactome. Furthermore, we analyzed the proteomic effects of siRNA-mediated depletion of the Sec62-interacting protein Sec63. We identified a comprehensive list of differentially regulated proteins, providing new insights into the molecular mechanisms of the cancer-related functions of Sec62 in cell migration, drug resistance, and Ca 2+ -homeostasis.
Introduction
In recent studies, we identified and characterized SEC62 as a potential new oncogene within the terminal 3q region that is frequently amplified in non-small cell lung cancer (NSCLC) [1] . We further found that SEC62 gene expression is significantly higher in squamous cell carcinoma (SCC) tumor tissue compared to normal lung tissue, and that Sec62 protein content is significantly elevated in SCC and adenocarcinoma (AC) tumor tissue [1] . In the tissue samples of 70 patients with stage I-III plasmid-driven over-expression of SEC62. We recently also found an influence of Sec62 on cellular calcium homeostasis. First siRNA-mediated Sec62 depletion leads to higher cytosolic calcium concentrations [4] , and second plasmid-based overexpression of a SEC62 gene containing a mutation in a potential EF-hand motif results in the same molecular and cellular phenotypes as seen in Sec62 depletion [2] . Furthermore, a recent systematic gain-and loss-of-function screen in immortalized human mammary epithelial cells found that SEC62 is a major cancer driver within the 3q26 amplicon [5] .
In addition to our research with respect to the cancerrelated functions of Sec62, this protein has also been investigated as an accessory component of the proteinconducting Sec61-complex, which can directly interact with ribosomes and thereby regulate translation [6] . Sec62 is also reportedly involved in small protein secretion [7] and post-translational translocation of ppcecA into the ER [8] . Furthermore, regarding the interaction of Sec62 with Sec63, a Hsp40 homologue protein known to directly bind Sec62 was shown to be regulated by CK2-mediated phosphorylation [9] . Despite great progress in understanding the function of Sec62 in protein transport to the ER and in cancer cell biology, the exact molecular mechanisms and signaling pathways behind these functions remain largely unknown.
In our present study, we used the 2D-DIGE technique to search for general proteomic alterations in SCC or AC tumors of the lung versus normal lung tissue. Since the tumor samples were preselected with respect to their Sec62 protein content, we further investigated whether such alterations depended on Sec62 over-production. In cell culture experiments, we specifically over-expressed a plasmid-encoded SEC62 and then compared the data derived from the different sources. We also present the complimentary results of studying the Sec62 interactome and the consequences of loss of Sec63, the major Sec62 interaction partner.
2.
Materials and methods
Cell cultures and tissue samples
The cell lines PC3 (DSMZ no. ACC 465), HEK293 (DSMZ no. ACC 305), and NIH3T3 (DSMC no. ACC 59) were cultured in DMEM medium (Gibco Invitrogen) containing 10% FBS (Biochrom) and 1% penicillin/streptomycin (PAA), at 37 • C in a humidified environment with 5% CO 2 . We generated HEK293 cell lines stably transfected with either a plasmid encoding the wild-type SEC62 gene (pSEC62-IRES-GPF) or an empty control plasmid (pIRES-GPF) as previously described [1] . Further cultivation and all experiments using the stably transfected cell lines were performed in normal growth medium containing 1% G418. Tissue samples were obtained from 70 lung cancer patients with pathologically confirmed AC or SCC. These samples were dissected by a pathologist, sorted into cancerous and healthy portions, snap frozen, and stored at −80 • C. The cancer samples were verified to have >80% tumor cell content by microscopic evaluation of HE-stained cryostat sections. Samples were only used if the patients gave signed informed consent, following the guidelines of the local ethics board.
Protein quantification in cultured cells by western blot
To quantify proteins in the cell culture samples, lysates of 2 × 10 5 cells per preparation were subjected to western blot analysis using an affinity-purified polyclonal rabbit antibody directed against the carboxy-terminal undecapeptide of human Sec62, a rabbit anti-peptide antiserum directed against CLIMP-63 (PSAKQRGSKGGHC plus CLFVKVEKIHEKV), and an affinity-purified polyclonal rabbit antibody directed against Sec63 N380. For loading controls, we also used a polyclonal anti-␤-actin (Sigma-Aldrich, A5441-.5ML) or anti-GAPDH antibody (Santa Cruz Biotechnology, FL-335). Vimentin was detected using an anti-Vimentin-Cy3 antibody conjugate (Sigma-Aldrich, C-9080). Bound primary antibodies were visualized with an ECL TM Plex goat-anti-rabbit IgG-Cy5 (GEHealthcare, PA-45012) or ECL TM Plex goat-anti-mouse IgG-Cy3 conjugate (GE-Healthcare, PA-43010) and the Typhoon-Trio imaging system (GE-Healthcare) with the Image Quant TL software 7.0 (GE-Healthcare). The ratios of Sec62, Sec63, or Vimentin to ␤-actin or GAPDH were determined.
2.3.
Immunofluorescence staining
Immunofluorescence double-staining was performed on stably transfected HEK293 cells cultured on glass slides in 6-cm dishes. The cells were washed with PBS, fixed in formaldehyde (3.7% in PBS) at room temperature for 8 min, and permeabilized with 0.2% Triton X-100 and 1% BSA in PBS on ice for 5 min. Then the cells were washed with PBS three times, and non-specific binding sites were blocked by incubation in BSA (1% in PBS). Subsequently, the cells were incubated for 60 min with the above-described specific antibodies against Sec62 or Vimentin-Cy3, or with phalloidin-FITC (Life Technologies, F-432). Sec62 was visualized using a secondary goat-antirabbit-FITC antibody conjugate (Dianova, 111-095-144). Cell nuclei were stained with DAPI.
Silencing of gene expression by siRNA
For gene silencing, 5 × 10 5 NIH3T3 cells were seeded per 6-cm dish in normal culture medium. The cells were transfected with SEC63 siRNA (GGGAGGUGUAGUUUUUUUAtt, Ambion), SEC62 siRNA (GGCUGUGGCCAAGUAUCUUtt, Ambion), or control siRNA (AllStars Neg. Control siRNA, Qiagen, 1027281) using HiPerFect Reagent (Qiagen, 301807) following the manufacturer's instructions. After 24, 72, and 144 h, the medium was changed and the cells were transfected again. Silencing efficiency was evaluated by western blot analysis.
Proteomic analysis by 2-D difference gel electrophoresis (2D-DIGE)
HEK293 cells stably overexpressing SEC62 encoded on a pSEC62-IRES-GFP-plasmid, as well as control cells transfected with an empty pIRES-GFP control plasmid, were cultured for 24 h in six independent 25-cm 2 culture flasks. The cells were then trypsinized, harvested, counted, and washed twice with PBS buffer. NIH3T3 cells were cultured and transfected with Sec63 siRNA or control siRNA as described above. At 192 h after For each experimental approach, 10 6 cells were suspended in 100 L labeling buffer (7 M Urea, 2 M Thiourea, 65 mM CHAPS, and 25 mM Tris/HCl pH 8.75) and homogenized for 30 s in a MP FastPrep24 homogenizer. Then the proteins were purified using a 2-D Clean-Up kit (Amersham) and quantified using a 2-D Quant kit (Amersham) following the manufacturer's instructions. Tissue samples were snap frozen in liquid nitrogen, and mechanically lysed with a pestle and mortar. Proteins were then isolated using the illustra triplePrep kit (GE Healthcare) following the manufacturer's instructions, and quantified as described.
Six pooled samples were prepared from the tissue of 14 AC or 16 SCC patients by mixing the isolated proteins from two or three patients for each sample. These samples were selected based on their Sec62 protein content as determined by western blot analysis [1] , resulting in a mean Sec62 overexpression of 4.2-fold (SCC) or 2.3-fold (AC). From the same patients, matched tumor-free tissue samples were also prepared and pooled in the same manner. The protein extracts were mixed with 0.4 nmol of either Cy3, Cy5, or Cy2 fluorescent dye (GE Healthcare) per 50 g total protein, and subsequently incubated on ice for 30 min. The reaction was stopped by adding 1 mol l-lysine. In the DIGE analysis, tumor samples (either SCC or AC) and tumor-free tissue samples were labeled with Cy3 or Cy5 dye, and compared using a Cy2-labeled mixture of both as an internal standard. We used six gels (representing six biological replicates) comparing SCC to normal tissue, and six gels comparing AC to normal tissue. Each gel included dye swaps between tumor and normal tissue to avoid biases by incommensurable labeling reactions.
Finally, the gels were scanned with a Typhoon Trio scanner (GE Healthcare) at a resolution of 100 m, and protein spots [10] . d An n-fold regulation of the spot; a negative value stands for an up-regulation in the tumor, a positive value for a down-regulation.
were detected with the DeCyder software (GE-Healthcare, version 6.5) with the target spot number set to 2000. For further analysis, we selected spots meeting the following criteria: presence in at least five out of six biological replicates (SCC samples and cell cultures) or in four out of five biological replicates (AC samples); statistically significant regulation in all replicates, with a p value < 0.05; relative regulation of at least 1.5-fold (higher or lower). All regulated spots matching these criteria were picked from the gel and analyzed by nano-LC-MS/MS. The resulting peptide sequences were assigned to proteins based on a database search (IPI human database, EBI), and their emPAI-values [10] were calculated. From the list of regulated proteins in the tissue samples, keratins and hemoglobin subunits were dismissed. For all 2D-DIGE analyses, the proteins identified in each spot were arranged by the emPAI-value and the two top listed proteins were selected for the tables, which are presented here. The original data are shown in the Supplement.
Co-immunoprecipitation
For co-immunoprecipitation, 6 × 10 8 HEK293 cells stably transfected with the pSEC62-IRES-GFP plasmid were harvested, suspended in 64 mL lysis buffer containing 20 mM HEPES/KOH pH 7.55, 1.5 mM MgCl 2 , 1 mM EDTA, 150 mM KCl, 0.65% CHAPS, and protease inhibitor (12 g/mL each pepstatin A, leupeptin, antipain, chrymostatin, and 200 M phenylmethylsulfonylfluoride). These cells were incubated for 1.5 h at 4 • C for cell lysis, and centrifuged at 257,000 × g for 20 min at 2 • C. Next, two 22.5 mL aliquots of the supernatant were incubated overnight at 4 • C: one with 0.5 mg of an affinity-purified polyclonal rabbit anti-peptide antibody directed against the COOH terminus of human Sec62, and the other with 0.5 mg of an affinitypurified polyclonal rabbit antibody directed against GST. Each antibody was pre-bound to protein A/G sepharose mix (Fastflow, GE Healthcare, 1:1). The suspension was subsequently transferred into a column (Mobi-Tec). After collecting the [10] . d An n-fold regulation of the spot; a negative value stands for an up-regulation in the tumor, a positive value for a down-regulation.
flow-through, the column was washed three times with the lysis buffer, and another three times with a washing buffer containing 50 mM Tris/HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P40, and the above-described protease inhibitor. Eight 500-L fractions of the bound material were eluted from the columns using washing buffer supplemented with 1 mg/mL of the peptide against which the anti-Sec62 antibody was directed to. The eluted proteins were precipitated following the method described by Wessel [11] , and then loaded on a SDS gel and stained with Coomassie brilliant blue. Protein bands were subsequently analyzed by nano-LC-MS/MS. The determined peptide sequences were assigned to proteins based on a database search (IPI human database, EBI), and emPAI-values [10] were calculated for each protein result. Proteins identified for each band were arranged by emPAI-values and the three top listed proteins were selected for the tables, which are presented here. Here also the molecular mass of the denatured protein was taken into consideration. The original data are shown in the Supplement.
Results and discussion

Proteomic comparison of tumor and normal tissue of the lung
In our first approach, we investigated the proteomic alterations in tumor samples derived from SCC or AC of the lung, which were compared to tumor-free lung tissue from the same patients. We analyzed paired fresh-frozen tissue samples from a total of 30 patients suffering from stage II or IIIA NSCLC (16 SCC and 14 AC) and undergoing surgical resection with a curative intention. This large number of patients allowed us to obtain statistically reliable data for each NSCLC subtype individually. In lung cancer, the genomic region 3q25-26 where the SEC62 gene is located has been shown to be more frequently amplified in squamous cell carcinoma (55-85%) compared to adenocarcinoma (25-30%) [12, 13] . Here we pooled the samples according to their previously determined Sec62 protein content [1] , creating six biological replicates, each including tissue samples from two to four cases. The relative Sec62 protein content in each pooled sample was again determined by western blot (Fig. 1) .
Using the 2D-DIGE approach for the SCC samples, we found 73 spots representing 49 different proteins that were significantly regulated in tumor compared to tumor-free lung tissue (relative protein abundance of 1.5-fold higher or lower) and detected in at least 5 of 6 replicates. Of these proteins, 24 were up-regulated and 25 were down-regulated. In the AC samples, we detected 59 spots representing 32 proteins meeting the afore-mentioned criterion for relative regulation and being present in at least 4 of 5 replicates. Of these proteins, 20 were up-regulated and 11 down-regulated. Eleven proteins were found to be significantly regulated in both SCC and AC tissue; five of the latter were up-regulated and six down-regulated, and in all cases, the observed regulation tended toward the same direction in both analyzed histological entities. Table 1 presents a detailed list of all identified proteins.
The protein dermcidin was found to be regulated in two spots in AC tissue, but the direction of regulation remained unclear, as one spot showed down-regulation (2.4-fold) while the other showed up-regulation (2.0-fold). This phenomenon might result from the post-translational modification that has been described for this protein, or from limited proteolysis leading to several truncated peptides [14, 15] . This 110 aminoacid secretory protein almost meets the criteria for small proteins that strongly depend on Sec62 for efficient translocation to the ER [7] . It also contains a large disordered region within its N-terminal sequence [15] , which might affect its translocation to the ER [16] . Therefore, the accumulation of modified or partially digested dermcidin derivates might be due to the influence of Sec62 on its translocation to the ER.
Among the regulated proteins, we also found an enrichment of proteins involved in ER-stress response, such as endoplasmin and BiP. Two previous studies using 2D-DIGE technology show that BiP is differentially abundant in thyroid cancer [17, 18] , and another important study demonstrates a crucial function of BiP in angiogenesis, and describes this protein as an effective target molecule for cancer anti-neovascular therapy [19] . Our present results also identified proteins with known functions in cell migration and invasion, such as hemopexin and Hsp70 1A/1B, and cytoskeleton-associated proteins, such as Vimentin, fascin, and cytoskeleton-associated protein 4 (CLIMP-63). Within these proteins CLIMP-63 is of special interest as this protein is normally controlling the ER-shape and the anchoring of microtubules to the ER in a phosphorylation and cellcycle dependent manner [20] . Studies investigating the effect of synthetic inhibitors (olomoucine, roscovitine) of cyclindependent kinases (CDK) on cancer cell proliferation and p53 protein content in human cancer cells unexpectedly found an increase of CLIMP-63 after olomoucine-treatment [21, 22] . Taken together, these results perfectly support our previous findings that SEC62-overexpressing tumors have a higher invasion potential and are protected against thapsigargin-induced ER stress [1, 3, 4] , as well as identify new and previously known proteins that are regulated in cancer. 
Specific alterations in the proteome of HEK293 cells induced by SEC62 overexpression
Next, we analyzed proteomic differences between HEK293 cells stably overexpressing a plasmid-encoded SEC62 gene (pcDNA3-SEC62-IRES-GFP) and control cells transfected with an empty-vector plasmid (pcDNA3-IRES-GFP). We used a nontumor-originated cell line in order to focus specifically on proteomic alterations caused by the increased amount of Sec62 protein. Within the six biological replicates used in 2D-DIGE experiments, the relative Sec62 protein levels in the SEC62-overexpressing cells ranged from 246 to 554% (Fig. 1) . As expected, we detected much fewer proteomic alterations as compared to our analysis of tumor material. Table 2 shows that we found only three spots (1258, 1259, and 1457) to be consistently regulated in all six biological replicates. Among these, we again identified Hsp70 1A/1B (1258 and 1259), which is described in the literature as having anti-apoptotic and carcinogenic effects [23] and as being a driving force for cancer cell migration and invasion [24, 25] . We also identified plastin 3 (1258 and 1259), an actin-binding protein harboring a potential calcium-binding site in its N-terminus, which was previously described as being down-regulated in A549 lung cancer cells after apoptosis induction [26] . Finally, we found Vimentin (1457), a well-established marker for epithelial-mesenchymal transition (EMT) [27] , which is known to be up-regulated in many cancer entities-including lung cancer, where it is associated with an unfavorable prognosis [27] and also considered as a "druggable" molecular target [28] . When including spots regulated in at least five of the six biological replicates, three more could be selected (1389, 1448, and 1473). All of these again represented Vimentin (1389 and 1448), and were regulated in the same direction as spot 1457. The third spot (1473) also contained serine/threonine-protein phosphatase 2A regulatory subunit A␣, PP2A A␣. This was a very interesting finding, because the interaction of Sec62 with Sec63 (a known binding partner of Sec62 in the ER membrane) was previously shown to depend on the phosphorylation status of Sec63, which is phosphorylated by CK2 [9] -and PP2A is a long-known antagonist of CK2 [29] . Additionally, PP2A mutations reportedly increase the incidence of lung cancer in mice [30] . In three of our six biological replicates, we identified the stress-induced phosphoprotein 1 (Hop1 or STIP1, spot 1325), which also reportedly plays a role in carcinogenesis [31] and is considered a prognostic biomarker in ovarian cancer [32] . Interestingly, the proteins Hsp70 1A/1B, Vimentin, and plastin 3 were identified as regulated in AC and/or SCC tumor tissue as well as in SEC62-overexpressing HEK293 cells, with the regulation tending toward the same direction in all cases. Hence, for these proteins, we suggest that the observed regulation is Sec62 dependent. To verify this assumption, we also examined the Vimentin protein content of the HEK293 cell lines used for 2D-DIGE analysis via western blot analysis and indirect immunofluorescence. Analyzing SEC62-overexpressing and non-overexpressing HEK293 cells with this technique, we found slightly increased Vimentin signal intensity in the former (Fig. 2A) . Western blot experiments revealed a 1.2-to 1.4-fold increase of the Vimentin protein content in HEK293 cells harboring the wild-type SEC62 encoding plasmid compared to the empty vector control (Fig. 2B) . As these values were on the borderline of western blot accuracy, we carefully evaluated the signal linearity for Vimentin, ␤-actin, and GAPDH (Fig. 2D) . The detection of Vimentin in tumor samples confirmed the increased Vimentin protein content in tumor compared to normal lung tissue (Fig. 2E) .
The same was true for CLIMP-63, a second cytoskeletonassociated protein that exhibited differential abundance in our SCC tumor sample approach but not in the DIGE analysis using the HEK293-cells. We detected a strongly increased signal in the SCC tumor samples, but hardly any signal in normal lung tissue (Fig. 3A and C) . To analyze whether this regulation really depended on the Sec62 protein level, we studied the CLIMP-63 protein content in HEK293 cells treated with SEC62 siRNA or control siRNA, and we found reduced CLIMP-63 protein content after Sec62 depletion. Furthermore, overexpression of SEC62 led to increased CLIMP-63 protein content. These cells exhibited a second band with an increased molecular weight, potentially indicating a post-translational modification ( Fig. 3B and D) . CLIMP-63 is regulated by phosphorylation during the cell cycle [20] .
Thus, overproduction of Vimentin and CLIMP-63 indeed depended on SEC62 overexpression in HEK293 cells. To directly study the influence of Sec62 on the actin rearrangement indicated by the regulation of this set of actin-interacting proteins, we stained f-actin with a phalloidin-FITC conjugate in PC3 cells that were either untreated or transfected with control siRNA or SEC62 siRNA. Our results revealed a rearrangement of the f-actin from being localized rather near the plasma membrane in the presence of Sec62, to being equally distributed throughout the cell after Sec62 depletion (Fig. 3E) . Thus, changes in calcium-induced actin rearrangement in the absence of Sec62 might contribute to the strongly reduced migration potential of these cells.
From the proteomic view to the interactome of Sec62
In addition to the alterations in tumor tissue and in SEC62-overexpressing cultured cells, we also studied the Sec62 interactome in HEK293 cells stably overexpressing the plasmid-encoded SEC62 gene. To this end, we performed coimmunoprecipitation experiments using an affinity-purified antibody directed against the COOH-terminal undecapeptide of Sec62 that was previously shown to be highly specific under native and denaturing conditions [3] . Table 3 summarizes all proteins that co-precipitated with Sec62, and Fig. 4 shows the respective Coomassie-stained SDS gel. Our results showed two Sec62-interacting proteins, Hsp70 1A/1B and Vimentin, both of which had previously shown a differential abundance in at least one of the tumor tissue samples and in the SEC62-overexpressing HEK293 cells. The co-immunoprecipitation results also showed several other proteins with functions related to the cancer phenotypes induced by SEC62 overexpression, including the cell division cycle and apoptosis regulator protein 1 (CCAR1), which is described as a key regulator of apoptosis signaling [33] , and the ELKS/Rab6 interacting protein (ERC-1), which is reportedly involved in the development of papillary thyroid carcinoma [34] .
Another highly interesting interaction partner of Sec62-especially with respect to its regulatory function in ER calcium homeostasis [2] -is striatin-3, a calmodulin binding [35] and PP2A-interacting protein [36] [37] [38] . Sec62 interacted with LETM1, which, like Sec62 itself, is an EF-hand-containing calciumbinding protein; however, due to its location in the inner mitochondrial membrane [39] , it is unlikely that its interaction with Sec62 is physiologically relevant. Prohibitin, which was also found to interact with Sec62 in this assay, is also located in the mitochondria but can be found in the plasma membrane as well [40] , making it a possible substrate for Sec62-dependent membrane insertion. Prohibitin is also linked to cancer-related functions, such as androgen receptor signaling [41] and regulation of cell proliferation [42] and apoptosis [43] . We also analyzed four bands, picked from the eluate of the GST-antibody-column. In three of these bands we found Hsp70 1A/1B, Vimentin and the putative elongation factor 1-alpha-like 3, i.e., the same proteins as compared to the Sec62-antibody-column. However, quantification showed much less interaction in the control (Fig. 4B ) and so also these candidates bound specific to Sec62. In summary, this approach revealed several intersections of the Sec62 interactome with the regulated proteins identified in the 2D-DIGE experiments, as well as highlighted several interesting candidate proteins in the context of cancer development, disease progression, or metastasis.
3.4.
Depletion of Sec63 leads to overlapping proteomic changes Next, we investigated the influence of Sec63 depletion on the cellular proteome, as this protein is a known interaction partner of Sec62 [9, 44, 45] and likewise part of the protein translocation machinery in the ER membrane. Furthermore, the SEC63 gene is among the most frequently mutated genes in hereditary nonpolyposis colorectal cancer-associated small-bowel cancer, and in sporadic cancers with frequent microsatellite instability [46, 47] . Here we depleted the Sec63 protein in NIH3T3 cells by repeated transfection with siRNA, evaluated the silencing efficiency by western-blot (supplementary Fig. S1A ), and subsequently used the lysates of six independent experiments for 2D-DIGE analysis. Interestingly, we found only four spots to be regulated by more than 1.5-fold (t-test: p < 0.5, appearance in more than 12 spot maps), representing four different proteins: cytoskeleton associated protein 4 (CLIMP-63), tyrosyl tRNA-synthetase, WD repeatcontaining protein 1, and prelamin A/C (supplementary Table  S1 and Fig. S1B) . Two of the proteins (CLIMP-63 and prelamin A/C) that were significantly up-regulated upon Sec63 depletion were also found to be up-regulated in the Sec62-overproducing SCC samples as compared to adjacent tumor-free lung tissue. Thus, it appears that these opposite changes in the Sec62 or Sec63 protein content both lead to the same effect: upregulation. As CLIMP-63 is an integral ER-membrane protein [20, 48] that influences the mobility of ER translocon complexes through its interaction with microtubules [49] , one might speculate that Sec62/Sec63 functions in regulating its membrane insertion.
Conclusions
Proteomic studies represent a powerful tool for investigating the biological background of a disease on the molecular level, and thus providing the detailed mechanistic insights necessary for developing new therapeutic strategies. To overcome the individual disadvantages of single experimental approaches, here we studied the proteomes of different SEC62 overexpressing tumor types, including SCC and AC of the lung, and of a more defined cell culture system specifically overexpressing SEC62. We investigated SEC62 overexpression because we previously characterized it as a new candidate oncogene [1] and it has been characterized as a cancer driver gene in NSCLC by others [5] . The results of the present study provide new insights into the complex molecular background of the tumor-related functions of Sec62. We identified three proteins regulated in SCC and/or AC as well as in the SEC62-overexpressing HEK293 cells-namely, HSP70 1A/B, plastin-3, and Vimentin. Of these, HSP70 1A/B and Vimentin also co-immunoprecipitated with Sec62, indicating a direct protein-protein interaction (Fig. 5) . We suggest that one or more of the observed cytoskeletal effects of SEC62 overexpression, together with altered calcium homeostasis, contribute to the hallmarks of SEC62-overexpressing (tumor) cells, i.e., increased migration potential and increased ER stress tolerance.
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